APA (7th ed.) Citation

Inderberg, E. M., Singh, N., Miller, R., Arbe-Barnes, S., Eriksen, H. K., lversen, B., . . . Handeland, K. R. (2025). Generation of frameshift-mutated TGFβR2-specific T cells in healthy subjects following administration with cancer vaccine candidate FMPV-1/GM-CSF in a phase 1 study. Cancer Immunology, Immunotherapy : CII, 74(4), 115-10. https://doi.org/10.1007/s00262-025-03969-6

Chicago Style (17th ed.) Citation

Inderberg, Else Marit, Nand Singh, Robert Miller, Sarah Arbe-Barnes, Henrik K. Eriksen, Berit lversen, Hedvig Vidarsdotter Juul, Jon Amund Eriksen, and Karianne Risberg Handeland. "Generation of Frameshift-mutated TGFβR2-specific T Cells in Healthy Subjects Following Administration with Cancer Vaccine Candidate FMPV-1/GM-CSF in a Phase 1 Study." Cancer Immunology, Immunotherapy : CII 74, no. 4 (2025): 115-10. https://doi.org/10.1007/s00262-025-03969-6.

MLA (9th ed.) Citation

Inderberg, Else Marit, et al. "Generation of Frameshift-mutated TGFβR2-specific T Cells in Healthy Subjects Following Administration with Cancer Vaccine Candidate FMPV-1/GM-CSF in a Phase 1 Study." Cancer Immunology, Immunotherapy : CII, vol. 74, no. 4, 2025, pp. 115-10, https://doi.org/10.1007/s00262-025-03969-6.